Chemical Component Summary

Name4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]amino}methyl)benzoic acid
Synonyms4-((4-carboxybutyl)(2-((4-phenethylbenzol)oxy) phenethyl) amino)methyl(benzoic) acid)
Identifiers4-[[(5-hydroxy-5-oxo-pentyl)-[2-[2-[(4-phenethylphenyl)methoxy]phenyl]ethyl]amino]methyl]benzoic acid
FormulaC36 H39 N O5
Molecular Weight565.699
TypeNON-POLYMER
Isomeric SMILESc1ccc(cc1)CCc2ccc(cc2)COc3ccccc3CC[N@@](CCCCC(=O)O)Cc4ccc(cc4)C(=O)O
InChIInChI=1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41)
InChIKeyWPYWMXNXEZFMAK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count81
Chiral Atom Count0
Bond Count84
Aromatic Bond Count24

Drug Info: DrugBank

DrugBank IDDB16126 
NameCinaciguat
Groups investigational
DescriptionCinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ΜG/h, 10 ΜG/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)).
SynonymsCinaciguat
Categories
  • Acids, Carbocyclic
  • Benzene Derivatives
  • Guanylate Cyclase
CAS number329773-35-5

Related Resource References

Resource NameReference
PubChem 9808022
ChEMBL CHEMBL1236936
ChEBI CHEBI:142433